A revolution in oncology could help the 18 million cancer survivors in the U.S. and bolster Guardant Health, Natera and Exact Sciences.

NEW YORK – Cardiff Oncology on Tuesday said it has completed enrolling patients with advanced RAS-mutated colorectal cancer in a Phase II trial testing the activity of its PLK1 inhibitor onvansertib ...

There has been a sharp increase in colorectal and pancreatic cancer rates among Americans under 55 years, despite declines in older adults, according to a new study.

Most people have never heard of Lynch Syndrome, but approximately one million Americans have inherited genes that cause the ...

The team is optimizing the cancer genome analysis system to integrate it into CRC diagnosis and tailor treatments based on genetic mutations.

Metastatic castration-resistant prostate cancer causes urinary symptoms, fatigue, pain, and more. This article covers the ...

The use of breast cancer screening and colorectal cancer screening is higher than the use of lung cancer screening.